Búsqueda | Portal de Búsqueda de la BVS España

1.

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Ledermann, J A; Matias-Guiu, X; Amant, F; Concin, N; Davidson, B; Fotopoulou, C; González-Martin, A; Gourley, C; Leary, A; Lorusso, D; Banerjee, S; Chiva, L; Cibula, D; Colombo, N; Croce, S; Eriksson, A G; Falandry, C; Fischerova, D; Harter, P; Joly, F; Lazaro, C; Lok, C; Mahner, S; Marmé, F; Marth, C; McCluggage, W G; McNeish, I A; Morice, P; Nicum, S; Oaknin, A; Pérez-Fidalgo, J A; Pignata, S; Ramirez, P T; Ray-Coquard, I; Romero, I; Scambia, G; Sehouli, J; Shapira-Frommer, R; Sundar, S; Tan, D S P; Taskiran, C; van Driel, W J; Vergote, I; Planchamp, F; Sessa, C; Fagotti, A.

Ann Oncol; 35(3): 248-266, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38307807

2.

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial.

Ray-Coquard, I; Leary, A; Pignata, S; Cropet, C; González-Martín, A; Marth, C; Nagao, S; Vergote, I; Colombo, N; Mäenpää, J; Selle, F; Sehouli, J; Lorusso, D; Guerra Alia, E M; Bogner, G; Yoshida, H; Lefeuvre-Plesse, C; Buderath, P; Mosconi, A M; Lortholary, A; Burges, A; Medioni, J; El-Balat, A; Rodrigues, M; Park-Simon, T-W; Dubot, C; Denschlag, D; You, B; Pujade-Lauraine, E; Harter, P.

Ann Oncol; 34(8): 681-692, 2023 08.

Artículo en Inglés | MEDLINE | ID: mdl-37211045

3.

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

Arch Gynecol Obstet; 307(4): 1155-1162, 2023 04.

Artículo en Inglés | MEDLINE | ID: mdl-36127525

4.

European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.

Vergote, I; González-Martín, A; Ray-Coquard, I; Harter, P; Colombo, N; Pujol, P; Lorusso, D; Mirza, M R; Brasiuniene, B; Madry, R; Brenton, J D; Ausems, M G E M; Büttner, R; Lambrechts, D.

Ann Oncol; 33(3): 276-287, 2022 03.

Artículo en Inglés | MEDLINE | ID: mdl-34861371

5.

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.

Heitz, F; Harter, P; Åvall-Lundqvist, E; Reuss, A; Pautier, P; Cormio, G; Colombo, N; Reinthaller, A; Vergote, I; Poveda, A; Ottevanger, P B; Hanker, L C; Leminen, A; Alexandre, J; Canzler, U; Sehouli, J; Herrstedt, J; Fiane, B; Merger, M; du Bois, A.

Gynecol Oncol; 152(2): 235-242, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30466805

6.

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer.

Vergote, I; du Bois, A; Floquet, A; Rau, J; Kim, J-W; Del Campo, J M; Friedlander, M; Pignata, S; Fujiwara, K; Colombo, N; Mirza, M R; Monk, B J; Tsibulak, I; Calvert, P M; Herzog, T J; Hanker, L C; Meunier, J; Lee, J-Y; Bologna, A; Carrasco-Alfonso, M J; Harter, P.

Gynecol Oncol; 155(2): 186-191, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31519320

7.

Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

González-Martín, A; Harter, P; Leary, A; Lorusso, D; Miller, R E; Pothuri, B; Ray-Coquard, I; Tan, D S P; Bellet, E; Oaknin, A; Ledermann, J A.

Ann Oncol; 34(10): 833-848, 2023 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-37597580

8.

Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland.

Dueckelmann, A M; Fink, D; Harter, P; Heinzelmann, V; Marth, C; Mueller, M; Reinthaller, A; Tamussino, K; Wimberger, P; Sehouli, J.

Arch Gynecol Obstet; 297(4): 847, 2018 04.

Artículo en Inglés | MEDLINE | ID: mdl-29445924

9.

The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.

Dueckelmann, A M; Fink, D; Harter, P; Heinzelmann, V; Marth, C; Mueller, M; Reinthaller, A; Tamussino, K; Wimberger, P; Sehouli, J.

Arch Gynecol Obstet; 297(4): 837-846, 2018 04.

Artículo en Inglés | MEDLINE | ID: mdl-29356953

10.

Treatment of recurrent ovarian cancer.

Pignata, S; C Cecere, S; Du Bois, A; Harter, P; Heitz, F.

Ann Oncol; 28(suppl_8): viii51-viii56, 2017 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-29232464

11.

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Oaknin, A; Bosse, T J; Creutzberg, C L; Giornelli, G; Harter, P; Joly, F; Lorusso, D; Marth, C; Makker, V; Mirza, M R; Ledermann, J A; Colombo, N.

Ann Oncol; 33(9): 860-877, 2022 09.

Artículo en Inglés | MEDLINE | ID: mdl-35690222

12.

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.

Bookman, M A; Okamoto, A; Stuart, G; Yanaihara, N; Aoki, D; Bacon, M; Fujiwara, K; González-Martín, A; Harter, P; Kim, J W; Ledermann, J; Pujade-Lauraine, E; Quinn, M; Ochiai, K.

Ann Oncol; 28(suppl_8): viii30-viii35, 2017 Nov 01.

Artículo en Inglés | MEDLINE | ID: mdl-29232472

13.

Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.

McGee, J; Bookman, M; Harter, P; Marth, C; McNeish, I; Moore, K N; Poveda, A; Hilpert, F; Hasegawa, K; Bacon, M; Gatsonis, C; Brand, A; Kridelka, F; Berek, J; Ottevanger, N; Levy, T; Silverberg, S; Kim, B-G; Hirte, H; Okamoto, A; Stuart, G; Ochiai, K.

Ann Oncol; 28(4): 702-710, 2017 Apr 01.

Artículo en Inglés | MEDLINE | ID: mdl-28119296

14.

Management of borderline ovarian tumors.

du Bois, A; Trillsch, F; Mahner, S; Heitz, F; Harter, P.

Ann Oncol; 27 Suppl 1: i20-i22, 2016 04.

Artículo en Inglés | MEDLINE | ID: mdl-27141065

15.

Neoadjuvant chemotherapy in ovarian cancer revisited.

Mahner, S; Trillsch, F; Chi, D; Harter, P; Pfisterer, J; Hilpert, F; Burges, A; Weissenbacher, T; du Bois, A.

Ann Oncol; 27 Suppl 1: i30-i32, 2016 04.

Artículo en Inglés | MEDLINE | ID: mdl-27141067

16.

Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).

Sehouli, J; Chekerov, R; Reinthaller, A; Richter, R; Gonzalez-Martin, A; Harter, P; Woopen, H; Petru, E; Hanker, L C; Keil, E; Wimberger, P; Klare, P; Kurzeder, C; Hilpert, F; Belau, A K; Zeimet, A; Bover-Barcelo, I; Canzler, U; Mahner, S; Meier, W.

Ann Oncol; 27(12): 2236-2241, 2016 12.

Artículo en Inglés | MEDLINE | ID: mdl-27789470

17.

Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.

Lheureux, S; Karakasis, K; Harter, P; Scott, C; Bacon, M; Bryce, J; Le Fur, N; Pujade-Lauraine, E; Oza, A M.

Gynecol Oncol; 140(1): 90-4, 2016 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-26475959

18.

Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.

Nagle, C M; Dixon, S C; Jensen, A; Kjaer, S K; Modugno, F; deFazio, A; Fereday, S; Hung, J; Johnatty, S E; Fasching, P A; Beckmann, M W; Lambrechts, D; Vergote, I; Van Nieuwenhuysen, E; Lambrechts, S; Risch, H A; Rossing, M A; Doherty, J A; Wicklund, K G; Chang-Claude, J; Goodman, M T; Ness, R B; Moysich, K; Heitz, F; du Bois, A; Harter, P; Schwaab, I; Matsuo, K; Hosono, S; Goode, E L; Vierkant, R A; Larson, M C; Fridley, B L; Høgdall, C; Schildkraut, J M; Weber, R P; Cramer, D W; Terry, K L; Bandera, E V; Paddock, L; Rodriguez-Rodriguez, L; Wentzensen, N; Yang, H P; Brinton, L A; Lissowska, J; Høgdall, E; Lundvall, L; Whittemore, A; McGuire, V; Sieh, W.

Br J Cancer; 113(5): 817-26, 2015 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-26151456

19.

Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.

Ataseven, B; Kümmel, S; Weikel, W; Heitz, F; Holtschmidt, J; Lorenz-Salehi, F; Kümmel, A; Traut, A; Blohmer, J; Harter, P; du Bois, A.

Arch Gynecol Obstet; 291(5): 1153-66, 2015 May.

Artículo en Inglés | MEDLINE | ID: mdl-25367604

20.

Head and neck cancer relapse after chemoradiotherapy correlates with CD163+ macrophages in primary tumour and CD11b+ myeloid cells in recurrences.

Balermpas, P; Rödel, F; Liberz, R; Oppermann, J; Wagenblast, J; Ghanaati, S; Harter, P N; Mittelbronn, M; Weiss, C; Rödel, C; Fokas, E.

Br J Cancer; 111(8): 1509-18, 2014 Oct 14.

Artículo en Inglés | MEDLINE | ID: mdl-25093488

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: